Tag: SYN

Blue Horseshoe Stocks: Fresh News Plays & More

NuGene International, Inc. NUGN

We’ve been tracking NUGN for a few weeks now, with our most recent focus coming on the 15th of this month. The stock has been making a good bit of progress on the chart since rebounding off of support at 2.64 a few days later on the 18th, and we want to draw extra attention to it this morning as a new PR has hit the wires.

From that recent swing low, NUGN has regained ground back to Friday’s high of 3.48, which marks a 32% rebound in a span of seven trading days. We’ll want to keep an eye out for a continued uptrend from this point forward.

This morning’s interesting news involves NuGene’s Kathy Ireland® product line, which has been selected by a high-volume cosmeceutical  e-commerce store, LovelySkin.com, as a premier line of business for its online outlet which serves hundreds of thousands of customers. >> READ PR

Kraig BioCraft Laboratories, Inc. KBLB

We want to tag KBLB as we kick off this short trading week for a couple of reasons. The first of which is the positioning of the current KBLB chart, which as you can see from the following snapshot, is searching out a bottom as it has come down off off the second major swing in as many months. Twice this spring, the stock surged from the .035-area to a nickel or more.

We’ll be looking to get in on some of the rebound action should history attempt to repeat itself, and this morning’s PR could be a good start along that path.

KBLB has developed what it is calling its strongest recombinant spider silk substance to date. In fact, the wonder-material they are dubbing Dragon SilkTM is actually stronger than natural spider silk! We’ll be interested to follow this storyline along with the good chance of seeing some significant short-term gain opportunities. >>READ PR

American Green, Inc. ERBB

We tracked ERBB quite a bit back when it traded as Tranzbyte Corp., and now that it goes by the American Green moniker, we’re seeing the materialization of what could be an upcoming move on the chart. It would come in the form of a bottom-bounce play; as you can plainly see, the stock has been on a rather steady decline for the past few months.

In addition to being heavily oversold, the company has some fresh press out today:

TEMPE, AZ–(Marketwired – Jun 29, 2015) – American Green, Inc. (OTC PINK: ERBB) is very pleased to announce today that it has executed an acquisition agreement with TrackX, LLC (www.TrackX.com). TrackX, a Denver-based company, is one of the country’s leading providers of complete Radio Frequency Identification (RFID) tracking and cloud-based physical asset management systems. >> FULL PR

Extended Watchlist:
IAG, CBLI, SYMX, WYY, SYN

Blue Horseshoe Stocks: ESPR Options, MVIS Recaps & More


Esperion Therapeutics, Inc. ESPR

ESPR found new highs once again yesterday for the second straight session after we initially tagged it for options trading potential on Tuesday.

In addition to monitoring Weekly In-the-money Calls, which yielded up the opportunity at gains ranging from 400-1400% on Tuesday, and continued their own runs yesterday, we also had specified a longer-term idea that continued to work extraordinarily well.

That idea, the 04/17 $90 Calls, traded from a low of 11.60 all the way up to 21.90 yesterday. It represented an excellent single-session intraday increase of 89%, and a whopping 525% jump over our observed low from Tuesday (3.50).

Big congratulations go out to any of our readers who reaped the benefits ESPR, which has easily emerged as our top target of the week! The stock is gapping up in the premarket this morning, so it appears as if we could see a further extension of those gains.

Microvision, Inc. MVIS

On Monday we tagged MVIS in a gap-up watchlist, and it has found its way into every one of our reports this week, setting new highs each day.

Yesterday the stock traded in a range from 3.42-4.23, a healthy intraday move of 24% From our observed low of 2.88 on Monday, that high marked a rise of 47% overall.

As you can see below, given the extremely over-bought look of the chart, now might be a good time to lock in any profits gained over the course of the week. This major move has been fueled by a PR out Monday in which the company announced orders totaling more than $14M it had received for components of its patented PicoP® display technology >> VIEW PR

Side Note:

Yesterday in advance of the FOMC Meeting, we cautioned readers to stay alert and watch for the effect that Janet Yellen’s commentary would have on the markets. To take advantage of this expected surge in either direction, we mentioned trading options calls on either the SPY, if the markets went up, or UVXY and/or VIX if they slid back.  Either way it played out, we said, we wanted “to stay in-the-money with our strike prices.”

As it turned out, the Fed announcement caused a sharp rise in the markets, and as a result the SPY Calls were the ones to play. We saw substantial gains on in-the-money Calls as the SPY spiked to $211.27.

For example, the SPY $209.50 Calls traded in a range from .80-2.00, for an intraday move totaling 150%  $210 Calls also spiked heavily from a low of .40 to as much as 1.59, a huge 297% jump.

Extended Watchlist:
FOLD, RAD, NQ, CNDO, SYN, SMLR

Blue Horseshoe Stocks: Commenting on PBR & More

Petroleo Brasiliero S.A. (Petrobras) PBR

Amid allegations of money-laundering and bribery which extend high up into the Brazilian government (including former PBR board member and President Dilma Rousseff) the sixth-largest energy company in the world, and a point of focus for us all year, could be forced to write down billions in assets and reduce dividends. The company’s Q3 financials are being delayed indefinitely as a result.

The long-term implications of such a scandal are too vast and varied for us to make even a brief assessment accurately. What we can do is stay extra tuned to the PBR newsfeed to stay as up-to-date as possible on current events and adhere to our technicals, because we can still see potential on the chart.

On Tuesday, PBR hit its all-time low of 8.80. but has since made higher lows and higher highs over the proceeding sessions. After we tagged it on Friday morning, there was a 9% intraday move from 10.08 to $11, and this morning the premarket high is 11.51, which will act as immediate resistance as the session kicks off. We’ll want to see support hold at roughly 10.85, but if PBR can break past this morning’s high to confirm its continued uptrend, the next thing we’d be looking for is the filling of a gap on the chart from approximately $12-12.50.

As far as options go, we’re presently looking at the Jan 17th $10 and $11 Calls, provided the current trend continues.

Prosensa Holdings (N.V.) RNA

RNA is a stock that we tracking periodically this spring and summer, and we just wanted to comment quickly on the buyout offer the company announced this morning. In a $680M deal, Prosensa will receive around $17.75/share from buyer BioMarin Pharmaceutical.

Following an alert we put out on RNA back in May, the stock was trading at a low of 7.96; this morning’s premarket high of $19 means we’ve seen more than a 130% move in this play over a span of about 5 months.

Extended Watchlist:
MOLG, GERN, CIMT, SYN, AEMD, MY